Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurotoxic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT01492920
What this trial is testing

Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy

Who this might be right for
FatigueMalignant Ovarian Mixed Epithelial TumorNeuropathy+10 more
Gynecologic Oncology Group
Not applicableStudy completedNCT03726580
What this trial is testing

Evaluation of Neurotoxic Effect of Sevoflurane-Based AnaesthesiaGuided by Short-Term Olfactory Identification

Who this might be right for
Neurotoxic Effect of Sevoflurane-Based Anaesthesia
Tanta University 600
Not applicableUnknownNCT01022450
What this trial is testing

Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients

Who this might be right for
RhabdomyolysisMyopathyAcute Renal Failure+1 more
National Taiwan University Hospital 2,500
Large-scale testing (Phase 3)Ended earlyNCT04857359
What this trial is testing

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 25
Not applicableStudy completedNCT05813145
What this trial is testing

Fenofibrate Role in Breast Cancer Patients

Who this might be right for
Breast Cancer
Damanhour University 50
Testing effectiveness (Phase 2)Study completedNCT05148884
What this trial is testing

Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia

Who this might be right for
Medication-Induced Dyskinesia
Neurolixis SAS 27
Large-scale testing (Phase 3)Study completedNCT01372774
What this trial is testing

Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery

Who this might be right for
Cognitive/Functional EffectsMetastatic CancerNeurotoxicity+2 more
Alliance for Clinical Trials in Oncology 194
Early research (Phase 1)Active Not RecruitingNCT03696784
What this trial is testing

Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma

Who this might be right for
LymphomaLymphoma, B-CellImmune System Diseases+2 more
UNC Lineberger Comprehensive Cancer Center 12
Post-approval studies (Phase 4)UnknownNCT04156464
What this trial is testing

Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit

Who this might be right for
Alcohol WithdrawalAlcohol Withdrawal Delirium
OSF Healthcare System 142
Post-approval studies (Phase 4)UnknownNCT00837707
What this trial is testing

Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

Who this might be right for
Dyskinesia, Drug-Induced
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 25
Testing effectiveness (Phase 2)Study completedNCT05963334
What this trial is testing

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Advanced Epithelial Ovarian Cancer
Cairo University 49
Not applicableStudy completedNCT06055088
What this trial is testing

Hand-Foot Exercises on Peripheral Neuropathy

Who this might be right for
Breast CancerNeuropathy
Amasya University 79
Testing effectiveness (Phase 2)Study completedNCT00792142
What this trial is testing

Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell NeoplasmNeurotoxicity
City of Hope Medical Center 45
Not applicableNot Yet RecruitingNCT07715994
What this trial is testing

A Computer-Assisted Tool for Objective Assessment of Extrapyramidal Symptoms

Who this might be right for
Extrapyramidal SymptomsDrug-induced ParkinsonismAkathisia, Drug-Induced+1 more
Shanghai Mental Health Center 180
Not applicableUnknownNCT00671866
What this trial is testing

Neurotoxic Health Hazards of Long-Term Low-Level Exposure to Organophosphate (OP) Compounds in in Hula Valley

Who this might be right for
Peripheral Neuropathy
Shaare Zedek Medical Center
Not applicableWithdrawnNCT01923376
What this trial is testing

Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)

Who this might be right for
Hepatic EncephalopathyHECirrhosis+2 more
New York Presbyterian Brooklyn Methodist Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT05972135
What this trial is testing

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 100
Testing effectiveness (Phase 2)Ended earlyNCT01789047
What this trial is testing

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's DiseaseDrug Induced Dyskinesia
Rush University Medical Center 42
Large-scale testing (Phase 3)Ended earlyNCT00301080
What this trial is testing

D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain

Who this might be right for
NeurotoxicityPainBreast Cancer
Northwestern University 7
Testing effectiveness (Phase 2)Looking for participantsNCT07106671
What this trial is testing

A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma

Who this might be right for
CRS - Cytokine Release SyndromeMyeloma
Institute of Hematology & Blood Diseases Hospital, China 20
Next Page